Thomas A. D’Amico, MDShaf Keshavjee, MD

James D. Luketich, MDBryan F. Meyers, MD, MPH

Scott J. Swanson, MD

Anesthesiology Cardiology Cardiothoracic Surgery Critical Care Emergency Medicine EndovascularGeneral Surgery Interventionalist Pulmonary Medicine Robotic Surgery Oncology Other

CANCELLATIONS

All requests for cancellations must be received in writing by Thursday, October 25, 2012. The registration fee, less a $100.00 administrative fee, will be refunded after the meeting.Requests received after this date will not be honored unless a special request is forwarded to LungCancer@aats.org.

Please make checks (in U.s. fUnds) Payable to:

aats focus on thoracic surgery: lung cancer500 Cummings Center, Suite 4550Beverly, MA 01915Phone: 978-927-8330Fax: (978) 524-0461w w w. a a t s . o r g / L u n g C a n c e r

Registration form

Please contact me regarding special needs.

Special Accessibility Needs:

Please charge my registration fees to the following credit card:

MasterCard Visa American Express

Name as it Appears on the Credit Card:

Billing Address of Card Holder: Same as above or

City: State: Zip:

(See card images below.) Where is your card Security Code? Your credit card’s security code is a 3- or 4- digit number located on its front or back.

Credit Card #: Expiration Date:

Security Code:

Signature:

On or BEFORE 10/25/12

On or AFTER10/26/12 TOTAL

Name:

Hospital/Affiliation:

Address:

City: State: Zip Code:

Country: Phone: Fax:

E-Mail:

Registration fees

method of Payment

I would like to pay by check (enclosed)

TOTAL AMOUNT DUE: $

Primary specialty (check one):Adult Cardiac Congenital General Thoracic Vascular Other:

AATS Member

Physician

Fellow / Resident

Allied Health

Exhibitor/Distributor

Non-exhibiting Industry Personnel

$550 $650 $

$650 $750 $

$250 $350 $

$350 $450 $

$100 $200 $

$650 $750 $

aats

involved in (check all that apply):

locationaats focus on thoracic surgery: lung cancer will be held at the Boston Marriott Copley Place, 110 Huntington Avenue, Boston, Massachusetts. The hotel is located in downtown Boston within walking distance to restaurants, theaters and attractions.

hotel accommodationsA block of rooms has been reserved for the symposium participants at the Boston Marriott Copley Place. The room rate for the Focus on Thoracic Surgery: Lung Cancer is $199.00 per night plus 14.45% state and local taxes. The hotel reservation deadline is Thursday, October 25, 2012 at 6:00 pm EDT.

ROOM RATESSingle: $199.00Double: $199.00Additional Person: $20.00

METHOD OF RESERVATIONSTo make your hotel reservation online, visit our website at www.aats.org/lungcancer or call 1 (800) 228-9290 or (617) 236-5800 to make your reservation directly with the hotel. Please be sure to mention that you are with the Focus on Thoracic Surgery: Lung Cancer Summit, reservation code aat, to receive the discounted group rate.

GUARANTEED RESERVATIONSAll reservations must be accompanied by a first night room deposit or guaranteed with a major credit card. Hotel will not hold any reservations unless secured by one of the above methods.

CUTOFF DATEReservations by attendees must be received on or before 6:00 pm EDT, Thursday, October 25, 2012.

exhibiting and educational supportTo learn more about exhibiting and educational support opportunities, contact Yvonne Grunebaum at ygrunebaum@prri.com.

Registration information To register please visit our website at www.aats.org/LungCancer or return the form by mail or fax to:

Focus on Thoracic Surgery: Lung Cancer500 Cummings Center, Suite 4550Beverly, MA 01915Phone: (978) 927-8330Fax: (978) 524-0461Email: lungcancer@aats.org

No registrations will be accepted over the phone. The pre-registration deadline is thursday, october 25, 2012. To register after October 25, please complete the registration form and bring it with you to the Onsite Registration Desk at Focus on Thoracic Surgery: Lung Cancer.

American Association for Thoracic Surgery500 Cummings Center, Suite 4550Beverly, MA 01915Ph. 978.927.8330

, Usa

AATS

Program overviewLung cancer is the second most common malignancy in the Western world and the most common cause of cancer-related death. Recent innovations in diagnosis, staging and management of early stage and locally advanced non-small cell lung cancer have changed the paradigm for surgical management of lung cancer patients. A virtual explosion of technological development has enabled widespread use of minimally invasive approaches which current and future thoracic surgeons must embrace to improve the care of patients with lung cancer. The AATS has chosen to highlight these recent developments in its inaugural “Focus on Thoracic Surgery” program. The faculty includes internationally recognized experts in lung cancer and application of new technology for its surgical management.

Program committee membersG. Alec Patterson, MD, Program DirectorDavid J. Sugarbaker, MD, Program DirectorThomas A. D’Amico, MDShaf Keshavjee, MDJames D. Luketich, MDBryan F. Meyers, MD, MPHScott J. Swanson, MD

educational objectivesUpon completion of this course, participants will be able to:

� Understand the current role of endoscopic strategies for lung cancer diagnosis and staging

� Learn the advantages and limitations of limited resection for early stage lung cancer

� Appreciate the role of surgical resection in patients with locally advanced and nodal metastatic disease

� Understand the various approaches to minimally invasive pulmonary resection

� Understand the technical challenges and results of extended pulmonary resection

� Learn the current role of stereotactic body radiotherapy (SBRT) in the management of early stage non-small cell lung cancer

target audienceThis conference is designed to meet the educational needs of:

� Thoracic Surgeons � Pulmonologists � Radiologists � Thoracic Oncologists � Primary Care Physicians � Residents/Fellows � Nurses � Physician Assistants � Allied Health Professionals

accreditationThe American Association for Thoracic Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This live activity has been approved for 17 ama PRa category 1 creditstm.

disclosure PolicyIt is the policy of the American Association for Thoracic Surgery that any individual who is involved in planning, presenting or is an author on a program designated for ama Physician’s Recognition award category 1 credit™ must disclose any financial interest or other relationship (grant, research support, consultant, etc.) that individual has with any manufacturer(s) of any commercial product(s) that may be discussed in the individual’s presentation. This information is disclosed to the audience prior to an activity. The AATS has procedures in place if a conflict of interest should arise. In addition, faculty members are asked to disclose when any discussion of unapproved use of pharmaceutical or medical device occurs. 

For further information on the Accreditation Council for Continuing Medical Education (ACCME) Standards of Commercial Support, please visit www.accme.org. 

Raphael bueno, md, facsAssociate Chief, Division of Thoracic SurgeryBrigham and Women’s Hospital; Professor of Surgery, Harvard Medical School

traves d. crabtree, mdAssistant Professor, Washington University School Of Medicine

thomas a. d’amico, mdProfessor and Vice Chairman of Surgery, Chief, Section of General Thoracic Surgery, Program Director, Thoracic Surgery, Duke University Medical Center

todd l. demmy, md, facsClinical Chair, Department of Thoracic Surgery, Professor of Oncology, Roswell Park Cancer Institute, Associate Professor of Surgery, School of Medicine and Biomedical Sciences, State University of New York at Buffalo

hiran c. fernando, md, facsDirector, Center for Minimally Invasive Esophageal Surgery, Associate Professor of Cardiothoracic Surgery, Cardiothoracic Surgery Center for Thoracic Oncology, Boston University School of Medicine, Boston MA

bruce e. Johnson, mdDirector, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; Professor of Medicine, Harvard Medical School

david R. Jones, mdProfessor of Surgery and Biochemistry & Molecular Genetics, Vice- Chair of Clinical Affairs and Quality, Division Chief, Thoracic & Cardiovascular Surgery, University of Virginia

shaf keshavjee, md, msc, fRcsc, facsSurgeon-in-Chief, James Wallace McCutcheon Chair in Surgery, Director, Toronto Lung Transplant Program, Program Medical Director Surgical Services and Critical Care UHN; Director, Latner Thoracic Research Laboratories; Scientist, McEwen Center for Regenerative Medicine; Professor, Division of Thoracic Surgery & Institute of Biomaterials and Biomedical Engineering, University of Toronto

James d. luketich, mdProfessory of Cardiothoracic Surgery, University of Pittsburgh Medical Center

Robert J. mckenna, Jr., mdCo-Director and Surgical Director, Women’s Guild Lung Institute, Program Director, General Thoracic Surgery Fellowship, Cedars Sinai Medical Center

bryan f. meyers, md, mPhPatrick and Joy Williamson Endowed Chair in Cardiothoracic Surgery, Chief, Section of Thoracic Surgery, Washington University School of Medicine

keith s. naunheim, mdProfessor, Saint Louis University School of Medicine; Director, Division of Cardiothoracic Surgery, St. Louis University Cancer Center

mark onaitis, mdAssociate Professor of Surgery, Duke Cancer Institute

G. alec Patterson, mdEvarts A. Graham Professor, Surgery, Chief, Division of Cardiothoracic Surgery, Washington University School of Medicine

Joe b. Putnam, Jr., mdIngram Professor of Cancer Research, Professor and Chairman, Department of Thoracic Surgery, Program Director, Thoracic Surgery, Professor of Biomedical Informatics, Vanderbilt University Medical Center

david J. sugarbaker, mdChief, Division of Thoracic Surgery, Brigham and Women’s Hospital

scott J. swanson, md, facsChief Surgical Officer, Disease Center Leader, Surgical Oncology, Professor of Surgery, Brigham & Women’s Hospital; Harvard Medical SchoolDana Farber Cancer Institute

Garrett l. Walsh, mdProfessor of Surgery, The University of Texas MD Anderson Cancer Center

douglas e. Wood, mdProfessor and Chief, Division of Cardiothoracic Surgery, Vice-Chair, Department of Surgery, Endowed Chair in Lung Cancer Research, University of Washington

cameron d. Wright, mdProfessor of Surgery, Division of Thoracic Surgery,Massachusetts General Hospital

kazuhiro yasufuku, md, PhdDirector, Interventional Thoracic Surgery Program, Toronto General Hospital; Assistant Professor of Surgery, University of Toronto

P R o G R a m a G e n d a

faculty

A M E R I C A N A S S O C I AT I O N F O R T H O R A C I C S U R G E RY | F O C U S O N T H O R A C I C S U R G E R Y: L U N G C A N C E R | N O V E M B E R 1 6 – 1 7 , 2 0 1 2 | B O S TO N M A R R I OT T C O P L E Y P L A C E | B O S TO N , M A , U S A | W W W. A AT S . O R G / LU N G C A N C E R

Program information

fRiday, noVembeR 16, 2012 7:00 a.m. Registration and Continental Breakfast 7:30 a.m. Welcome and Introduction Drs. Patterson and Sugarbaker

session i: diagnosis and staging moderator: dr. sugarbaker 7:40 a.m. CT Screening for Lung Cancer – Dr. Jones7:55 a.m. Navigational Bronchoscopy – Dr. Yasufuku 8:10 a.m. EBUS/EUS – Dr. Crabtree 8:25 a.m. VAMLA/TEMLA – Dr. Demmy 8:40 a.m. Mediastinoscopy vs. VATS – Dr. Patterson 8:55 a.m. Marker Driven Pathology Reports – Are they Useful? – Dr. Johnson 9:10 a.m. Panel Discussion Drs. Crabtree, Demmy, Johnson, Jones, Patterson, and Yasufuku9:35 a.m. Break

session ii: managing small tumorsmoderator: dr. luketich 10:00 a.m. Wedge Plus Brachytherapy – Dr. Fernando10:15 a.m. SBRT, RFA, Cryo and other Technologies – Dr. Luketich 10:30 a.m. Thoracoscopic Segmentectomy – Dr. Swanson10:45 a.m. Open Segmentectomy – Dr. Wood 11:00 a.m. Complications: Best Ways to Avoid and How to Handle Difficult Ones – Dr. Fernando 11:15 a.m. Panel Discussion Drs. Fernando, Luketich, Swanson, and Wood 11:45 a.m. Lunch: My Best Care Path for VATS Lobe: You Will Not Miss What You Do Not Need – Dr. McKenna

session iii: surgery for 3a – b diseasemoderator: dr. Patterson 1:00 p.m. Restaging After Induction Therapy – Dr. Keshavjee1:15 p.m. Role of Resection for Persistent N2 Disease – Dr. Bueno 1:30 p.m. Bronchial Sleeve - Arterioplasty Following Induction Therapy – Dr. Wood 1:45 p.m. Pneumonectomy Post Induction Therapy – Dr. Putnam, Jr. 2:00 p.m. Surgery for N3 Disease – Dr. Walsh 2:15 p.m. Panel Discussion Drs. Bueno, Keshavjee, Putnam, Jr., Walsh, and Wood 2:45 p.m. Break

session iV: “can you make an inoperable tumor operable – the Role of induction chemo and Radiotherapy in lung cancer”moderator: dr. keshavjee 3:15 p.m. Imaging Tips Regarding Evaluation and ReEvaluation of Invasion of Critical Structures – Dr. Sugarbaker 3:30 p.m. Restaging the Primary Tumor – Dr. Wright 3:45 p.m. Pancoast Resection – Dr. Patterson 4:00 p.m. Resection of T4 Tumors – Dr. Keshavjee 4:15 p.m. En-Bloc Vertebrectomy – Dr. Walsh 4:30 p.m. Panel Discussion Drs. Keshavjee, Patterson, Sugarbaker, Walsh, and Wright

5:00 p.m. Adjourn

satURday, noVembeR 17, 2012 7:00 a.m. Continental Breakfast

session V: minimally invasive Resectionmoderator: dr. swanson 7:30 a.m. Thoracoscopic Lobectomy – Dr. D’Amico 7:45 a.m. Complex Thoracoscopic Lobectomy and Pneumonectomy – Dr. Demmy 8:00 a.m. Thoracoscopic Lobectomy: Hybrid Chest Wall Resection – Dr. D’Amico 8:15 a.m. Robotic Lobectomy – Dr. Onaitis 8:30 a.m. Lymph Node Dissection – Dr. Swanson 8:45 a.m. Complications: Best Ways to Avoid and How to Handle Difficult Ones – Dr. McKenna 9:00 a.m. Panel Discussion Drs. D’Amico, Demmy, McKenna, Onaitis, and Swanson 9:30 a.m. Break

session Vi: complex Resectional techniques moderator: dr. d’amico 10:00 a.m. Sleeve Resection – Dr. Jones 10:15 a.m. Pulmonary Arterioplasty and Vena Cava Reconstruction – Dr. Meyers 10:30 a.m. Carinal Pneumonectomy – Dr. Wright 10:45 a.m. Extrapleural/Pneumonectomy – Dr. Sugarbaker 11:00 a.m. Complications: Best Ways to Avoid and How to Handle Difficult Ones – Dr. Putnam, Jr. 11:15 a.m. Panel Discussion Drs. Jones, Meyers, Putnam, Jr., Sugarbaker, and Wright 11:45 a.m. Lunch: How Can NCCN Guidelines, NSQUIP, and the STS Database Improve your Outcomes and Efficiency of Care? – Dr. Naunheim

session Vii: sbRtmoderator: dr. meyers 1:00 p.m. Comparing Outcomes of SBRT to Outcomes of Surgery – Dr. Crabtree 1:15 p.m. Current Trials Comparing SBRT to Surgery: Should you be Involved? – Dr. Meyers 1:30 p.m. Economics of SBRT and Lung Cancer – Dr. Naunheim 1:45 p.m. Tissue Diagnosis and Staging for SBRT – Dr. Yasufuku 2:00 p.m. Strategies for Treating Failed SBRT Patients – Dr. Luketich 2:15 p.m. Panel Discussion Drs. Crabtree, Luketich, Meyers, Naunheim, and Yasufuku 2:45 p.m. Break

session Viii: Video/case Presentationsmoderator: dr. swanson 3:15 p.m. Management of Intraoperative Bleeding: VATS/Robot 3:30 p.m. VATS Sleeve Resection 3:45 p.m. VATS after Thoracotomy 4:00 p.m. Treatment of Space and Air Leak at Time of Resection 4:15 p.m. My Worst Complication 4:30 p.m. Biggest Stapler Mishap

5:00 p.m. Adjourn

AAT S